Status:
RECRUITING
Promotion of Vaginal Health With CH2 Vaginal Gel After Pelvic Radiotherapy
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Gynecologic Malignancy
Eligibility:
FEMALE
20-70 years
Phase:
NA
Brief Summary
This is a prospective clinical trial planning to enroll female patients who have completed pelvic radiotherapy. Participants will undergo a 12-week intervention with either CH2 vaginal gel or vaginal ...
Detailed Description
This is a prospective clinical trial planning to enroll female patients who have completed pelvic radiotherapy. Participants will undergo a 12-week intervention with either CH2 vaginal gel or vaginal ...
Eligibility Criteria
Inclusion
- Female patients aged between 20 and 70 years.
- Completion of pelvic radiotherapy for gynecologic cancer, which may include external beam radiotherapy (EBRT), brachytherapy (BT), or a combination of both.
- Eastern Cooperative Oncology Group (ECOG) performance status score of 0-1.
Exclusion
- Individuals under the age of 18.
- Presence of distant metastases or a history of malignancy currently under treatment within the past five years (excluding non-melanoma skin cancer).
- Presence of severe comorbidities, such as uncontrolled diabetes, cardiovascular disease, or autoimmune disorders that may interfere with treatment or study participation.
- Diagnosed psychiatric disorders or significant social factors that may prevent adherence to study requirements or completion of follow-up evaluations.
- Inability to self-administer vaginal gel or vaginal rehabilitation exercises.
Key Trial Info
Start Date :
May 9 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 9 2030
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06997887
Start Date
May 9 2025
End Date
May 9 2030
Last Update
June 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Cancer Center
Taipei, Taiwan